OBIO Precision Medical Industry Base Project

Founded in 2013, OBIO Technology (Shanghai) Corp., Ltd. is a biotechnology company focusing on the field of gene therapy. It specializes in providing CRO services, such as the development of gene therapy vectors, gene function research, drug target, and efficacy study for the basic research of gene therapy, and CDMO services, such as process development and testing, IND-CMC pharmaceutical research, and GMP production of clinical samples for the R&D of gene drugs. The self-control project location is the 77,000m2 precision medical industry base under construction in the Lingang section of Shanghai Pilot Free Trade Zone. Project Standard: GMP cGMP

AUSTAR Solution

Project Scope: From design consulting to implementation of the digital factory - Consultation and design services for the digital factory - End to end business process sorting - Compliant, efficient, and energy-saving intelligent utilities Building Management System

AUSTAR Value & Client Benefits

• This project required for detailed business consultation covering top-level planning and virus production line for suspended cell production • AUSTAR planed the direction of digital construction based on OBIO's business characteristics to ensure forward-looking digital construction • We helped client save investment by flexible solutions • The utility automation adoptted the latest control strategies to optimize energy-saving operation and saved operating costs for the client • Electronic signatures and records throughout the entire production process ensure the integrity of GMP data • Computer system validation based on ISPE GAMP5 is easier to pass global system certification

Contact Us